Clinical Oncology - Issue 6/2024
Editorial
403
Reviews
408
Diagnostic-therapeutic management of pulmonary nodules
V. Červeňák, Z. Chovanec, A. Berková, J. Resler, T. Hanslík, M. Kelblová, K. Novosádová, V. Weiss, O. Bílek, J. Vaníček
420
Autoimmune pancreatitis as a risk factor of pancreatic cancer
D. Solil, P. Dítě, B. Kianička, M. Bojková, M. Uvírová, M. Přecechtělová, J. Dolina
Original Articles
427
The treatment combination of obinutuzumab, bendamustine and dexamethasone achieved a deeper response than the previous line of treatment in five patients with Waldenström‘s macroglobulinemia
Z. Adam, L. Pour, M. Krejčí, V. Sandecká, M. Štork, I. Boichuk, Z. Král
433
Current real-world evidence on characteristics and treatment patterns of lung cancer in the single cancer center in the Czech Republic – data from Masaryk Memorial Cancer Institute registry in 2018– 2022
O. Bílek, I.- Selingerová, M. Kysela, V. Jedlička, T. Kazda, J. Berkovcová, P. Turčáni, A. Poprach, I. Kiss, M. Svoboda, L. Zdražilová-Dubská
Case Reports
451
Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström’s macroglobulinemia
Z. Adam, M. Krejčí, L. Pour, B. Weinbergerová, V. Sandecká, M. Štork, I. Boichuk, Z. Řehák, M. Keřkovský, R. Koukalová, L. Zdražilová-Dubská, B. Čechová, Z. Král
463
An atypical presentation of bronchogenic cyst
H. Matsumoto, S. Hasegawa, Y. Maezawa, S. Okauchi, G. Ohara, K. Iguchi, H. Kawai, N. Takayashiki, H. Satoh
Clinical Oncology
2024 Issue 6
Most read in this issue
- Editorial
- Diagnostic-therapeutic management of pulmonary nodules
- The treatment combination of obinutuzumab, bendamustine and dexamethasone achieved a deeper response than the previous line of treatment in five patients with Waldenström‘s macroglobulinemia
- Successful treatment of relapsed Waldenström’s macroglobulinemia with proteasome inhibitors (bortezomib and subsequently ixazomib) in combination with rituximab and dexamethasone. A case report and review of the of proteasome inhibitors in Waldenström’s macroglobulinemia